Literature DB >> 27160571

Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis.

Karl Dichtl1, Johannes Wagener2, Johannes Tschöp3, Ludwig Ney3.   

Abstract

Here, we report a patient developing a postoperative peritoneal infection by Aspergillus fumigatus. While galactomannan serum levels were negative throughout the time course, galactomannan levels in peritoneal fluids yielded high results. Serological testing of peritoneal fluids for fungal antigens might be a useful and easily applicable tool to support diagnosis of intraabdominal aspergillosis, which represents a rare type of invasive fungal infection.

Entities:  

Keywords:  Antigen; Ascites; Aspergillus; Galactomannan; Peritonitis

Mesh：

Substances：

Year:  2016        PMID： 27160571     DOI： 10.1007/s15010-016-0902-2

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  21 in total

1.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

2.  Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients.

Authors:  Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Sun Bean Kim; Hye-Won Kim; Su Jin Jeong; Chang Oh Kim; Young Goo Song; June Myung Kim
Journal:  Scand J Infect Dis       Date:  2012-03-04

3.  Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue.

Authors:  Thomas Lehrnbecher; Martina Becker; Dirk Schwabe; Ulrike Köhl; Susanne Kriener; Klaus-Peter Hunfeld; Helga Schmidt; Peter Beyer; Thomas Klingebiel; Peter Bader; Jan Sörensen
Journal:  Pediatr Infect Dis J       Date:  2006-05       Impact factor: 2.129

4.  (1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study.

Authors:  Navaporn Worasilchai; Asada Leelahavanichkul; Talerngsak Kanjanabuch; Nisa Thongbor; Pichet Lorvinitnun; Kanya Sukhontasing; Malcolm Finkelman; Ariya Chindamporn
Journal:  Med Mycol       Date:  2015-05       Impact factor: 4.076

5.  Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis.

Authors:  Christoph Lichtenstern; Christina Herold; Markus Mieth; Thorsten Brenner; Sebastian Decker; Cornelius J Busch; Stefan Hofer; Stefan Zimmermann; Markus A Weigand; Michael Bernhard
Journal:  Mycoses       Date:  2015-05-25       Impact factor: 4.377

6.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

7.  Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity.

Authors:  Julia Jensen; Jesús Guinea; Marta Torres-Narbona; Patricia Muñoz; Teresa Peláez; Emilio Bouza
Journal:  J Infect       Date:  2009-11-20       Impact factor: 6.072

8.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Invasive Aspergillus infection localized to the gastric wall: report of a case.

Authors:  Ibrahim Karaman; Ayşe Karaman; Esin Cengiz Boduroğlu; Derya Erdoğan; Gönül Tanır
Journal:  Surg Today       Date:  2012-08-03       Impact factor: 2.549
View more
  3 in total

1.  Biomarkers of fungal infection: Expert opinion on the current situation.

Authors:  E Bouza; B Almirante; J García Rodríguez; J Garnacho-Montero; M Salavert; P Muñoz; M Sanguinetti
Journal:  Rev Esp Quimioter       Date:  2019-11-14       Impact factor: 1.553

2.  Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest.

Authors:  Alba Leyva Calero; Roberto Alonso; Ignacio Gadea; María Dolores Montero Vega; Marta Martín García; Patricia Muñoz; Marina Machado; Emilio Bouza; Julio García-Rodríguez
Journal:  Microbiol Spectr       Date:  2022-03-09

3.  An invasive infection caused by the thermophilic mold Talaromyces thermophilus.

Authors:  Karl Dichtl; Özlem Koc; Johannes Forster; Christina Scharf; Sebastian Suerbaum; Joachim Andrassy; Johannes Wagener; Ines Schroeder
Journal:  Infection       Date:  2021-06-30       Impact factor: 3.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.